← Back to Search

Behavioural Intervention

Smartphone-Based Attention Training for Substance Use Disorders (ATS Trial)

N/A
Waitlist Available
Led By Robert Leeman, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-month-follow-up
Awards & highlights

ATS Trial Summary

This trial is testing a new method, delivered via smartphone app, to see if it can help with attention, cravings, and substance use. The team wants to know if the app is feasible and what people think of it. Eligible participants will use the app for 2 weeks and attend 4 appointments.

Who is the study for?
This trial is for English-speaking individuals on Suboxone or methadone, with opioid use disorder but not severe substance use disorders besides opioids, nicotine, or cannabis. Participants must be able to engage with a smartphone app multiple times daily for two weeks and attend four study appointments.Check my eligibility
What is being tested?
The study tests an attention training method delivered via a smartphone app designed to influence attention and reduce cravings and substance use. Over two weeks, participants will provide feedback on the app's effectiveness and user experience.See study design
What are the potential side effects?
Since this intervention involves using an application on smartphones rather than medication, traditional side effects are not expected. However, users may experience eye strain or headache from frequent device use.

ATS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-month-follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-month-follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in attentional bias (AB)
Completion of daily assessments and attendance at study appointments.
Modified System Usability Scale scores overall and comparisons between study conditions
Secondary outcome measures
Change in craving levels
Change in opioid use
Change in pain levels
+4 more

ATS Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Attentional Training GroupActive Control1 Intervention
Each condition involves use of a smartphone app. One smartphone app includes a task that targets attention directed to substance-related cues while the other app includes a similar task that does not target attention in this way. Neither participant nor the staff members working on the study will know which condition the participant has been randomly assigned to.
Group II: Control Training GroupPlacebo Group1 Intervention
Each condition involves use of a smartphone app. One smartphone app includes a task that targets attention directed to substance-related cues while the other app includes a similar task that does not target attention in this way. Neither participant nor the staff members working on the study will know which condition the participant has been randomly assigned to.

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,340 Previous Clinical Trials
715,654 Total Patients Enrolled
Robert Leeman, PhDPrincipal InvestigatorUniversity of Florida
3 Previous Clinical Trials
122 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

May I partake in this medical study?

"This clinical study is open to 24 participants aged 18-65 with attention issues. In order to qualify, they must also be able and willing to answer questions on their smartphone up to four times a day for 10 minutes each time, available for six weeks of participation in the trial, and using Suboxone or methadone (or transdermal patch if recruitment does not progress as planned) for at least one month which will be verified by both urine drug test (unless using transdermal patch due to 1/3 of patients receiving false positives from urine tests) and opioid replacement therapy provider."

Answered by AI

Is the current medical trial open to individuals aged 25 or over?

"This trial seeks participants aged 18 to 65. On the other hand, there are 75 trials targeting those younger than 18 and 255 for individuals over 65 years old."

Answered by AI

Is the trial currently open to new participants?

"According to clinicaltrials.gov, this medical experiment is currently not looking for volunteers; its initial post date was September 1st 2019 and the latest update was August 30th 2022. Despite this trial being on hiatus, there are 361 other trials actively accepting subjects right now."

Answered by AI

What is the objective of this trial to determine?

"This clinical trial's primary aim is to observe any modifications in attentional bias (AB) over a two-week post-intervention period. Additionally, researchers are investigating the durability of training effect on opioid use and pain levels compared to control groups by using self-report data and urinalysis at 1 month follow up; as well as evaluate whether AB retraining can reduce opioid usage during the course of treatment."

Answered by AI
~4 spots leftby Apr 2025